OpRegenĀ® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026

Go back to OpRegenĀ® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
(NYSE: LCTX) Delayed: 1.25 -0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 727,881       

(NYSE: LCTX) Delayed: 1.25 -0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 727,881